Users of the pharmaceutical drug Tepezza have experienced complications, including hearing loss, thyroid eye disease flare-ups, and the need for a second treatment. Tepezza is supposed to help those suffering from thyroid eye disease, which causes inflammation and protrusion of the eye. The drug was fast-tracked to the market without proper testing by the Federal ...

The post Tepezza Users Require a Second Treatment to Course to Treat Thyroid Eye Disease appeared first on Dolman Law Group.